Zimbabwe has declined a significant US health deal valued at $367m (£272m) over five years because of Washington's demand for sensitive data.
This move became public after a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa felt the agreement was "unbalanced".
A government spokesman later stated that the US was requesting health data for research and profit while was unwilling to guarantee the resulting advantages from future treatments.
"We will now turn to the difficult and regrettable task of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had furnished over $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged further dialogue to secure a agreement agreeable to both sides so the nation's vital HIV programme can proceed.
Broader Implications
This development follows a similar case in neighbouring Kenya, where a high court suspended a similar deal with the US after concerns were raised about the security of citizens' health data.
After returning to office recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the US government, but Trump stated its expenditure was "inefficient" and his government was pursuing direct bilateral deals to boost openness and accountability.
According to statements, Sixteen African countries have to date signed similar health pacts, constituting more than $18.3bn in new funding.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration might have yielded significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported programmes," the Ambassador added.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data for a long time, with no equivalent guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"Put simply, our nation would provide the raw materials for medical research without any certainty that the end products would be available to our people if a new pandemic emerge."
National Interest and Global Health
He also pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were undermining systems already set up through the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential global health emergencies.
"This framework is intended to guarantee that when a country contributes its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.
"We are open to continued discussions with our American counterparts on how future collaboration could be structured in a manner that honours the sovereignty and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but recommended that talks must proceed given that much of the nation's Aids initiatives depended on external financing.
"Where specific concerns exist, such as those involving information security or implementation frameworks, these can frequently be resolved via detailed discussion and mutually agreed protections," it said.
The halted deal highlights the ongoing tensions between accepting vital international aid and protecting a country's data in an ever more interconnected world.